U.S. Custom Prosthetics and Orthotics Market

Market Outlook

By 2032, the U.S. Custom Prosthetics and Orthotics Market is projected to reach approximately USD 3.57 billion, expanding at a CAGR of 9.07% during the forecast period 2027–2032. The market is valued at USD 2.12 billion in 2026, following expansion from USD 1.67 billion in 2023 to USD 1.80 billion in 2024 and USD 1.95 billion in 2025. Values in this report are expressed in USD billions.

The market covers patient-specific prosthetic and orthotic systems that require individualized clinical assessment, anatomical measurement, design, fabrication, fitting, adjustment, or component configuration. It includes custom lower- and upper-limb prostheses, sockets, liners, ankle-foot orthoses, knee-ankle-foot orthoses, spinal orthoses, upper-extremity orthoses, cranial remolding systems, custom foot orthoses, digitally designed devices, 3D-printed systems, and advanced prosthetic configurations incorporating microprocessor, hydraulic, sensor-based, or myoelectric components. Prefabricated braces requiring only routine sizing, generic supports, wheelchairs, rehabilitation services, and surgical implants are outside the core market definition.

The U.S. has one of the world’s deepest clinical ecosystems for customized O&P care. More than 5.6 million Americans are living with limb loss or limb difference, including over 2.3 million people with limb loss, creating a substantial long-term prosthetic-care population. Demand is reinforced by diabetes, peripheral vascular disease, traumatic injury, stroke, arthritis, neurological impairment, congenital limb difference, spinal deformity, post-surgical rehabilitation, and age-related mobility loss.

Clinical demand is becoming more complex rather than simply larger. Patients and referring physicians increasingly expect devices to deliver improved gait mechanics, pressure distribution, stability, functional independence, socket comfort, cosmetic acceptance, and measurable mobility outcomes. This is changing the economic center of the market from basic fabrication toward high-value personalization.

The historical period from 2023 through 2025 was characterized by accelerating digital scanning, CAD/CAM workflows, advanced socket technologies, lighter composite materials, adjustable interfaces, microprocessor components, additive manufacturing, and greater integration between prosthetists, orthotists, physiatrists, orthopedic surgeons, physical therapists, rehabilitation hospitals, and payer utilization-management teams.

The forecast progression supports market expansion from USD 2.31 billion in 2027 to USD 2.52 billion in 2028, USD 2.75 billion in 2029, USD 3.00 billion in 2030, USD 3.27 billion in 2031, and USD 3.57 billion by 2032. Growth is expected to increasingly favor providers and manufacturers that can combine clinical customization with digital reproducibility, outcomes documentation, faster turnaround, payer-compliant documentation, and long-term device management.

Introduction

According to the U.S. Custom Prosthetics and Orthotics Market Report, personalization is becoming the defining commercial and clinical characteristic of advanced O&P care. Custom devices differ structurally from mass-produced mobility products because successful treatment depends on the relationship between the device, patient anatomy, residual-limb condition, biomechanics, strength, range of motion, functional goals, disease progression, and expected activity level.

CMS defines a custom-fabricated device as one individually made for a specific patient using clinically derived casts, tracings, measurements, or other anatomical images. Medicare quality standards additionally require suppliers providing custom-fabricated or custom-fitted O&P devices to maintain the capabilities needed for follow-up adjustment, modification, maintenance, and repair. This framework strengthens the role of qualified O&P clinicians and makes customization more than a manufacturing attribute; it is a longitudinal clinical service model.

The addressable population extends well beyond amputees. Approximately 53.2 million U.S. adults have diagnosed arthritis, creating substantial demand for orthopedic support, unloading, stabilization, and deformity-management solutions. More than 795,000 Americans experience a stroke each year, supporting continuing need for ankle-foot orthoses, upper-extremity positioning devices, gait-assist orthoses, and other neurorehabilitation products. The U.S. population aged 65 and older reached more than 61 million in 2024, increasing the number of patients experiencing arthritis, balance impairment, neurological disease, diabetic complications, weakness, and mobility-limiting conditions.

Diabetes is particularly important to the custom prosthetics ecosystem. About 38.4 million U.S. adults have diabetes, and diabetes-associated hospitalizations included approximately 166,000 lower-extremity amputations in 2021. Long-term demand therefore extends across the care pathway from custom diabetic foot orthoses and pressure-management devices to post-amputation sockets, lower-limb prostheses, replacement components, and recurring residual-limb management.

This is also a clinician-constrained market. U.S. Bureau of Labor Statistics data show roughly 9,500 orthotist and prosthetist jobs in 2025, with employment projected to increase approximately 13% from 2025 to 2035. The relatively small specialized workforce makes fabrication efficiency, centralized manufacturing, digital workflow standardization, remote consultation, automated design, and additive manufacturing strategically important.

Commercial success depends on four related capabilities: access to referral networks, clinical fitting expertise, payer documentation capabilities, and lifecycle support. Unlike many medtech categories, a high-performance component cannot generate its full value independently of the clinician who selects, configures, aligns, fits, and adjusts it. Manufacturers therefore compete not only through product engineering but through practitioner education, software, fitting tools, clinical evidence, reimbursement support, distribution, and compatibility with established fabrication workflows.

Key Market Drivers: What’s Fueling the U.S. Custom Prosthetics and Orthotics Market Boom?

The first major driver is the growing prevalence of chronic conditions that impair mobility. Diabetes, vascular disease, arthritis, obesity, neurological disease, and age-related musculoskeletal deterioration create a recurring need for customized support and mobility systems. More than 53 million U.S. adults live with diagnosed arthritis, while adults aged 45 years and older account for the overwhelming majority of arthritis cases. This produces a large addressable population for knee, ankle, spinal, wrist, hand, and foot orthotic intervention.

The second driver is the large and persistent limb-loss population. More than 2.3 million Americans are living with limb loss, while the broader limb loss and limb difference population exceeds 5.6 million. Prosthetic demand is inherently recurring because socket geometry may change with residual-limb volume, weight, age, activity, tissue condition, alignment needs, and rehabilitation progression. Patients may consequently require new sockets, liners, suspension systems, feet, knees, hands, elbows, or complete configurations over their lifetime.

The third driver is the rising clinical emphasis on functional outcomes rather than basic device provision. For lower-limb prostheses, Medicare coverage decisions consider functional potential using K-level classifications. Higher-function users may qualify for advanced components where medical necessity is demonstrated. Similar outcome-oriented purchasing behavior is increasingly visible among commercial payers, rehabilitation hospitals, workers’ compensation programs, and integrated health systems.

The fourth driver is digital customization. Traditional plaster casting and manual modification remain clinically relevant, but optical scanners, structured-light systems, tablet-based scanning, pressure mapping, CAD/CAM, digital rectification, and central fabrication platforms are changing how patient geometry is captured and reproduced. Digital files reduce dependence on physical molds, enable easier design revisions, facilitate remote collaboration, and make longitudinal anatomical comparison more practical.

The fifth driver is additive manufacturing. 3D printing can produce test sockets, definitive components, orthoses, prosthetic interfaces, and patient-specific geometries that may be difficult to fabricate efficiently using subtractive techniques. Published clinical work has demonstrated 3D-printed custom silicone liners and check sockets, with digital workflows capable of shortening parts of the fabrication cycle. Additive manufacturing is therefore increasingly relevant where clinics need repeatability, complex geometry, lighter devices, distributed production, or faster design iteration.

The sixth driver is demographic aging. Americans aged 65 and older now represent a rapidly expanding portion of the population. Older adults have substantially higher prevalence of arthritis, stroke, diabetes, balance impairment, muscle weakness, and vascular disease. The custom O&P opportunity is therefore extending from highly active amputees toward mobility preservation, fall-risk reduction, joint stabilization, post-stroke walking, and maintenance of community ambulation.

Hospital economics also support customized mobility care when the device can enable earlier rehabilitation, improve transfer safety, reduce falls, preserve independence, or facilitate discharge. Rehabilitation hospitals and health systems increasingly examine O&P care as part of the complete episode from surgery or acute injury through inpatient rehabilitation, outpatient therapy, home transition, and long-term mobility.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in custom prosthetics is increasingly concentrated around the interface between the patient’s body and the device. Even highly advanced knees, feet, or hands can underperform when socket comfort, suspension, pressure distribution, alignment, or residual-limb accommodation is inadequate. Adjustable sockets, vacuum systems, elevated-vacuum suspension, flexible inner sockets, anatomical contouring, breathable liners, advanced silicone interfaces, and user-adjustable volume systems are therefore commercially significant.

Microprocessor prosthetic knees remain an important premium technology. Broader payer recognition of advanced knee technologies for appropriate lower-function users is expanding the addressable population beyond historically high-activity amputees. The strategic implication is important: component innovation is increasingly being paired with individualized gait goals, safety requirements, fall-risk management, and payer-specific functional documentation.

Upper-limb innovation is moving toward more personalized myoelectric control. Modern systems can combine multi-articulating hands, modular wrists, multiple grip patterns, application-based configuration, pattern recognition, and individualized electrode positioning. In September 2026, Ottobock introduced its speedhand solution in the U.S., integrating the prosthetic hand, modular wrist options, myoelectric control, cuff technology, and app-based programming. The direction of travel is toward systems that allow prosthetists to configure a platform around the patient’s anatomy, muscle signals, occupation, and daily activities.

Pediatric prosthetics is also becoming more specialized. Smaller hydraulic knees, lightweight dynamic-response feet, water-resistant components, growth accommodation, and age-specific alignment strategies are improving options for children and adolescents. Pediatric devices have particularly attractive replacement dynamics because children require new sockets and components as they grow.

Orthotic innovation is moving toward thinner, lighter, more dynamic systems. Carbon composites and high-performance thermoplastics enable orthoses to provide stability without excessive bulk. In neurological care, stance-control and microprocessor-controlled orthoses can provide more adaptive support than locked mechanical systems for selected users.

The fastest structural change, however, is the digitization of the clinician-fabricator workflow. Scanning can be integrated with CAD design, centralized modification, automated carving, CNC milling, and additive manufacturing. A digital patient file can also preserve anatomical geometry across visits, potentially making replacements and design comparisons more efficient.

Artificial intelligence is likely to enter the market less as an autonomous clinician and more as a design and decision-support layer. Future applications include automated scan cleanup, shape recognition, rectification suggestions, alignment assistance, gait analysis, pressure-data interpretation, component recommendation, and identification of patients at risk of skin breakdown or device abandonment.

Segmentation Insights

The U.S. Custom Prosthetics and Orthotics Market is segmented on the basis of product type, clinical application, technology and fabrication method, material, end user, and geography.

By Product Type

Custom Prosthetics

Custom prosthetics account for approximately USD 0.90 billion in 2026, representing about 42.5% of market revenue. Lower-limb systems dominate this category because transtibial, transfemoral, hip-disarticulation, and partial-foot amputations require individualized sockets and alignment while supporting recurring demand for liners, suspension systems, knees, feet, pylons, adapters, and replacement interfaces.

Lower-limb custom prosthetics account for approximately USD 0.69 billion of the market. Diabetes and vascular disease remain critical underlying drivers, with 166,000 diabetes-associated lower-extremity amputation hospitalizations documented in a single recent national surveillance year. Advanced value growth is being generated by microprocessor knees, energy-return feet, hydraulic ankles, elevated-vacuum systems, adjustable sockets, and lighter composite structures.

Upper-limb custom prosthetics represent a smaller but high-value category of approximately USD 0.13 billion. Myoelectric hands, multi-articulating terminal devices, custom sockets, body-powered systems, partial-hand prostheses, activity-specific devices, and personalized control systems create considerably higher configuration complexity than generic assistive products.

Sockets, liners, and specialized interfaces represent approximately USD 0.08 billion when measured as separately identifiable custom replacement or interface revenue. Their strategic importance is larger than this value suggests because socket comfort and fit influence use time, gait quality, skin health, satisfaction, and the effective performance of the complete prosthesis.

Custom Orthotics

Custom orthotics account for approximately USD 1.22 billion in 2026, or 57.5% of the market, making orthotics the larger product category.

Lower-extremity orthoses represent approximately USD 0.53 billion. The segment includes custom AFOs, KAFOs, knee orthoses, custom foot and ankle systems, gait-correction devices, diabetic foot solutions, and neurological bracing. Stroke, cerebral palsy, multiple sclerosis, spinal cord injury, arthritis, instability, deformity, and post-operative rehabilitation sustain demand.

Custom spinal orthoses account for approximately USD 0.28 billion and include thoracolumbosacral, lumbosacral, cervical, scoliosis, post-operative, and deformity-management systems. Digital torso scanning and lighter materials are particularly important because adherence is strongly influenced by comfort, bulk, heat, cosmetic profile, and freedom of movement.

Cranial remolding and pediatric orthotic systems account for approximately USD 0.15 billion. Demand is concentrated in pediatric specialty networks and requires frequent reassessment because growth changes fit rapidly.

Upper-extremity custom orthoses generate approximately USD 0.13 billion, covering wrist-hand, elbow, shoulder, hand, finger, neurological positioning, contracture-management, and post-operative systems.

Custom foot orthoses and other personalized devices account for approximately USD 0.13 billion, supported by diabetic foot-risk management, deformity, plantar pressure redistribution, sports biomechanics, arthritis, and chronic foot and ankle dysfunction.

By Clinical Application

Limb Loss and Limb Difference

Limb loss and limb difference is the largest individual clinical application, representing approximately USD 0.78 billion in 2026. The U.S. has more than 5.6 million people living with limb loss or limb difference, creating a long-duration treatment population rather than a one-time procedural market. Lifetime prosthetic requirements can involve repeated sockets, component upgrades, repairs, alignment changes, liners, specialty devices, and activity-specific systems.

Musculoskeletal and Post-Surgical Conditions

Musculoskeletal and post-surgical indications account for approximately USD 0.56 billion. The 53.2 million U.S. adults with diagnosed arthritis form a large clinical base for joint unloading, stabilization, pain management, deformity accommodation, and mobility preservation. Orthopedic surgery also creates temporary and long-duration needs for spinal, knee, ankle, wrist, and upper-extremity stabilization.

Neurological Disorders

Neurological conditions account for approximately USD 0.34 billion. Stroke is central to this segment, with more than 795,000 cases occurring annually in the United States. AFOs, KAFOs, stance-control systems, upper-limb positioning devices, and contracture-management orthoses are used across stroke, cerebral palsy, multiple sclerosis, peripheral nerve injury, spinal cord injury, and neuromuscular disorders.

Diabetes and Vascular Disease

Diabetes- and vascular-related indications represent approximately USD 0.25 billion. This category captures custom foot orthoses, pressure-management products, partial-foot devices, post-amputation prostheses, and related patient-specific systems. Approximately 12% of people with diabetes may develop a diabetic foot ulcer during their lifetime, making prevention and pressure redistribution commercially important alongside post-amputation care.

Pediatric and Congenital Conditions

Pediatric and congenital applications represent approximately USD 0.19 billion. Children with limb difference, cerebral palsy, scoliosis, neuromuscular disease, cranial asymmetry, clubfoot, and developmental orthopedic conditions may require multiple device replacements during growth. Consequently, lifetime unit utilization can be significantly higher than a single fitting would suggest.

By Technology and Fabrication Method

Conventional Custom Fabrication

Conventional casting, molding, lamination, thermoforming, manual rectification, and bench fabrication account for approximately USD 0.82 billion in 2026. These methods remain clinically important for complex anatomy and situations where experienced practitioners rely on hands-on modification.

CAD/CAM and Digital Scanning

CAD/CAM and digitally scanned fabrication represent approximately USD 0.60 billion. This category is gaining share because it improves digital documentation, reproducibility, remote collaboration, centralized fabrication, and design storage. It also reduces the logistics associated with shipping casts and physical models.

Additive Manufacturing

3D printing and additive manufacturing represent approximately USD 0.20 billion and constitute the fastest-growing fabrication approach. Growth is being supported by printed check sockets, orthoses, molds, interfaces, and increasingly definitive devices. The opportunity is particularly strong where lightweight lattice structures, rapid iteration, or complex geometry provide a clinical advantage.

Advanced Mechatronic and Sensor-Integrated Custom Systems

Microprocessor, myoelectric, powered, hydraulic, sensor-assisted, and digitally configurable systems represent approximately USD 0.50 billion. These platforms command high average selling prices and require individualized programming and fitting. Their market share is expected to increase as coverage expands and manufacturers produce solutions for a broader range of functional levels.

By Material

Carbon Fiber and Advanced Composites

Carbon fiber and composite materials account for approximately USD 0.69 billion in 2026. They are heavily used in dynamic-response prosthetic feet, sockets, AFOs, KAFOs, and lightweight high-strength orthoses. Their stiffness-to-weight characteristics make them particularly attractive for active users and devices where energy return is important.

Thermoplastics and Engineered Polymers

Thermoplastics account for approximately USD 0.52 billion. Polypropylene and related materials remain foundational in custom orthotic fabrication because they can be molded, reheated, trimmed, and adjusted. Advanced polymers used in additive manufacturing are broadening the design possibilities within this category.

Silicone, Elastomers, and Interface Materials

Silicone and other elastomeric materials represent approximately USD 0.34 billion. Liners, custom interfaces, suspension systems, padding, pressure-management elements, and skin-contact components depend heavily on these materials. Their performance affects comfort, shear control, moisture management, and suspension.

Metals

Titanium, aluminum, stainless steel, and other metals account for approximately USD 0.37 billion. They remain important for joints, adapters, pylons, structural elements, modular prosthetic components, and high-load orthotic hardware.

Textiles, Leather, Foams, and Other Materials

Other materials account for approximately USD 0.20 billion and remain important in straps, padding, flexible interfaces, covers, footwear modifications, custom foot products, and specialized pediatric systems.

By End User

Prosthetic and Orthotic Clinics

Dedicated O&P clinics dominate the market with approximately USD 1.27 billion in 2026, or around 60% of market revenue. Their leadership reflects the clinical complexity of assessment, fitting, fabrication, adjustment, documentation, and long-term follow-up. Hanger Clinic alone operates approximately 900 locations nationwide and illustrates the scale that organized O&P networks can achieve.

Hospitals and Rehabilitation Centers

Hospitals, inpatient rehabilitation facilities, and hospital-affiliated outpatient programs account for approximately USD 0.36 billion. These facilities are particularly important immediately after amputation, trauma, stroke, spinal cord injury, orthopedic surgery, and complex neurological events.

Veterans Affairs and Military Care

VA, military, and related federal care settings account for approximately USD 0.21 billion. Veterans requiring advanced prosthetic or orthotic systems frequently present with complex traumatic, neurological, and mobility needs, making federal programs influential adopters of advanced O&P technologies.

Pediatric Specialty Centers

Children’s hospitals, pediatric O&P practices, scoliosis programs, and specialty rehabilitation centers represent approximately USD 0.17 billion. Growth-related replacement cycles and complex congenital or neurological presentations support recurring utilization.

Other Specialized Settings

Orthopedic practices, podiatry clinics, outpatient rehabilitation centers, sports-medicine programs, and other specialty settings account for approximately USD 0.11 billion.

Regional Insights: Where the Market is Growing Fastest

The U.S. Custom Prosthetics and Orthotics Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance is determined by population scale, age distribution, diabetes and vascular-disease prevalence, rehabilitation infrastructure, trauma volume, specialist availability, Medicaid policy, Medicare penetration, academic medical-center density, veterans’ care infrastructure, and access to certified O&P clinicians.

South

The South is the largest regional market, valued at approximately USD 0.75 billion in 2026, representing more than one-third of national custom O&P demand. The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, Maryland, Tennessee, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, West Virginia, Oklahoma, Delaware, and the District of Columbia within common regional market mapping.

Texas and Florida form the core of Southern demand. Texas had approximately 31.7 million residents in 2025, making it the second-largest state in the country. Its large metropolitan healthcare markets in Houston, Dallas-Fort Worth, Austin, and San Antonio support sophisticated prosthetic rehabilitation, trauma care, pediatric orthotics, and veteran populations. High diabetes prevalence in multiple Texas communities also supports demand for diabetic foot intervention and lower-limb prosthetic care.

Florida had approximately 23.5 million residents in 2025 and possesses one of the largest older-adult populations in the country. Its demographic profile creates substantial demand for arthritis-related bracing, stroke rehabilitation, lower-extremity orthoses, diabetic limb-loss care, and mobility preservation.

Georgia and North Carolina each exceed 11 million residents and are increasingly important custom O&P markets because of population growth, hospital expansion, orthopedic specialty networks, rehabilitation infrastructure, and migration of older adults into the Southeast.

Tennessee, South Carolina, Alabama, Mississippi, Louisiana, Kentucky, Arkansas, Oklahoma, and West Virginia carry substantial diabetes, cardiovascular, obesity, and mobility-related disease burdens. Their commercial challenge is geographic access. Large urban centers may support advanced myoelectric, microprocessor, and digital-fabrication technologies, while rural areas frequently depend on hub-and-spoke clinics, mobile services, or long travel distances.

Virginia and Maryland benefit from a strong mix of commercial healthcare, academic institutions, federal healthcare activity, military populations, and rehabilitation services. The presence of federal and military-related care makes these states disproportionately important for advanced prosthetics.

The Southern market is projected to reach approximately USD 1.22 billion by 2032, supported by population growth, chronic-disease burden, migration into Sun Belt states, expanding rehabilitation infrastructure, and continued penetration of advanced prosthetic technologies.

West

The West represents approximately USD 0.50 billion in 2026 and is projected to be the fastest-growing region, reaching roughly USD 0.90 billion by 2032, equivalent to a CAGR of approximately 10.3%.

California is the region’s dominant state and remains the largest U.S. state by population at approximately 39.4 million residents in 2025. It combines large academic health systems, children’s hospitals, rehabilitation programs, trauma centers, medtech development, digital-health expertise, advanced manufacturing, and strong adaptive-sports communities.

The California market is particularly receptive to digitally designed prostheses, 3D-printed systems, advanced upper-limb devices, microprocessor components, pediatric customization, and outcome-oriented rehabilitation. The state’s innovation ecosystem also supports collaborations between universities, engineers, O&P clinicians, software developers, and additive-manufacturing companies.

Arizona and Nevada represent attractive demographic-growth markets. Both states have growing older populations and strong inbound migration, increasing demand for arthritis bracing, lower-limb orthoses, stroke rehabilitation, and prosthetic services.

Washington and Oregon have sophisticated integrated health systems and strong adoption of digital workflows. Washington’s population exceeded 8 million in 2025, providing sufficient scale for advanced specialty O&P programs while maintaining a strong technology culture.

Colorado and Utah are important for sports-oriented prosthetic and orthotic care, rehabilitation innovation, and active-user products. Utah is also notable for companies involved in adjustable socket and patient-controlled fitting technologies.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller markets but highlight one of the industry’s most important problems: geographic access. Digital scanning, centralized design, teleconsultation, and distributed fabrication may generate disproportionate value in states where patients must travel long distances to reach specialty O&P practitioners.

Northeast

The Northeast accounts for approximately USD 0.46 billion in 2026 and is projected to reach about USD 0.75 billion by 2032.

New York is the dominant state market, with a population of approximately 20.0 million in 2025. The state supports major rehabilitation hospitals, academic medical centers, pediatric specialty institutions, trauma networks, and a dense referral environment. New York’s high provider density makes it an important market for advanced upper-limb prostheses, microprocessor lower-limb systems, post-stroke orthotics, pediatric bracing, and digitally enabled O&P care.

Pennsylvania had approximately 13.1 million residents in 2025 and has a mature network of health systems, rehabilitation providers, children’s hospitals, and O&P clinics. Its aging population and extensive orthopedic infrastructure make it particularly important for lower-extremity orthotics, spinal bracing, and post-surgical care.

Massachusetts has a smaller population base but outsized influence because of Boston’s concentration of academic medicine, rehabilitation research, engineering, robotics, and medical technology. The state is strategically important for early clinical evaluation of novel materials, digital fabrication, human-machine interfaces, and advanced prosthetic control.

New Jersey, Connecticut, Rhode Island, New Hampshire, Vermont, and Maine collectively support a high-value market characterized by relatively mature reimbursement, strong specialist networks, and significant Medicare utilization.

The Northeast is unlikely to produce the highest population-led growth, but it will remain one of the strongest regions for complex cases, academic collaboration, clinical evidence generation, and premium technology adoption.

Midwest

The Midwest represents approximately USD 0.41 billion in 2026 and is expected to reach roughly USD 0.70 billion by 2032.

Illinois is the region’s largest commercial market, with approximately 12.7 million residents in 2025. Chicago’s medical ecosystem supports advanced trauma care, pediatric rehabilitation, neurological orthotics, amputation rehabilitation, and major referral networks.

Ohio had approximately 11.9 million residents, while Michigan exceeded 10.1 million. Both states combine substantial chronic-disease burden with mature hospital and rehabilitation networks, making them important markets for prosthetic limbs, diabetic foot systems, AFOs, KAFOs, spinal orthoses, and post-operative bracing.

Minnesota has special strategic importance because of its established medtech and rehabilitation ecosystem. Wisconsin, Indiana, Missouri, Iowa, Kansas, and Nebraska provide stable demand through community health systems, orthopedic practices, rehabilitation programs, and regional O&P networks.

North Dakota and South Dakota represent smaller-volume states where centralized fabrication, regional referral centers, mobile care, and digital workflows are particularly relevant.

The Midwest is expected to deliver steady above-mature-market growth as digital fabrication reduces geographic disadvantages and health systems become more focused on functional outcomes, post-acute care, and chronic mobility management.

Key Market Players

The competitive landscape is fragmented across multinational component manufacturers, large national clinical networks, specialist fabricators, digital O&P technology companies, and highly focused custom-device innovators.

Hanger, Inc. / Hanger Clinic
Ottobock
Össur / Embla Medical
Blatchford
Fillauer
WillowWood Global
College Park Industries
PROTEOR USA
Becker Orthopedic
Boston Orthotics & Prosthetics
Orthomerica Products
Allard USA
Click Medical
Naked Prosthetics
Acor Orthopaedic

Hanger has the strongest nationwide clinical footprint, operating approximately 900 U.S. locations and treating custom prosthetic, orthotic, pediatric, cranial, and mobility patients across a national referral network. Its scale gives the company significant influence over clinical protocols, outcomes tracking, component purchasing, and relationships with health systems and payers.

Ottobock, Össur, Blatchford, Fillauer, WillowWood, College Park, and PROTEOR compete strongly across prosthetic feet, knees, sockets, liners, upper-limb solutions, components, suspension technologies, and advanced mobility systems. Competitive differentiation increasingly depends on how effectively components integrate into personalized fitting ecosystems.

Becker Orthopedic, Boston Orthotics & Prosthetics, Orthomerica, Allard USA, and Acor Orthopaedic maintain strong relevance across neurological, pediatric, lower-limb, spinal, foot, and specialty custom orthotics.

Click Medical is strategically important in adjustable socket technology, allowing patients to alter fit as residual-limb volume changes. Naked Prosthetics occupies a specialized position in custom partial-hand and finger prostheses, illustrating how highly focused companies can build defensible positions even in a market dominated by larger O&P groups.

Over the forecast period, market share will increasingly depend on clinical evidence, digital workflow capability, reimbursement support, practitioner education, centralized fabrication capacity, speed of delivery, product configurability, and compatibility with outcome-based care models.

Recent Developments

The U.S. custom O&P sector entered 2026 with significant momentum around advanced prosthetic access and personalized upper-limb technology. In September 2026, Ottobock launched its speedhand solution in the U.S., combining a new prosthetic hand with modular wrist options, myoelectric control technology, a cuff interface, and app-based programming. The launch demonstrates the industry’s transition toward configurable ecosystems rather than standalone terminal devices.

Pediatric innovation is another active area. New lower-limb products are increasingly being engineered specifically around children’s weight, gait, activity, durability, and growth rather than simply miniaturizing adult systems. Hydraulic pediatric knees, lightweight dynamic-response feet, and improved pediatric socket designs are expanding clinical options.

Coverage dynamics are also changing. During 2026, commercial payer policies continued to incorporate broader access to microprocessor knees for appropriately documented lower-function users following changes in Medicare lower-limb prosthetic policy. This is commercially significant because it expands the potential advanced-component population and increases the importance of functional assessment and medical-necessity documentation.

Hanger Clinic continues to strengthen the role of outcomes evidence in O&P care. Its 2025–2026 clinical research program emphasized translation of patient outcomes data into real-world practice, reinforcing the broader market movement toward measurable mobility, satisfaction, quality of life, and function.

Digital manufacturing continues to mature from experimental fabrication into commercial workflow infrastructure. Clinics are increasingly combining scanning, CAD rectification, remote design, centralized manufacturing, CNC milling, and additive manufacturing rather than choosing purely conventional or purely digital workflows.

Adjustability is another major innovation theme. Technologies that allow patients to manage day-to-day socket-volume changes can reduce the need for repeated temporary modifications and may improve comfort across changing physiological conditions. These systems are particularly valuable because residual-limb volume fluctuation remains one of the most persistent challenges in lower-limb prosthetic care.

The industry is simultaneously moving toward consolidation on the clinical side and specialization on the technology side. Large care networks benefit from payer relationships, purchasing power, standardized outcomes, and geographic reach, while smaller innovators can create strong positions around specific problems such as partial-hand restoration, adjustable sockets, digital fabrication, pediatric orthotics, or sensor-based mobility.

Conclusion

The U.S. Custom Prosthetics and Orthotics Market Size & Share is positioned to expand from USD 2.12 billion in 2026 to approximately USD 3.57 billion by 2032, reflecting a CAGR of 9.07% during the forecast period 2027–2032. Historical market expansion from USD 1.67 billion in 2023 to USD 1.95 billion in 2025 demonstrates that customization is capturing a growing share of the broader mobility and orthopedic-support ecosystem.

The opportunity is being created by a combination of chronic disease, limb loss, neurological disability, aging, musculoskeletal disorders, pediatric needs, reimbursement evolution, and rapid improvements in digital fabrication. More than 5.6 million Americans living with limb loss or limb difference, more than 53 million adults with arthritis, 38.4 million adults with diabetes, and over 795,000 annual strokes create a clinically diverse patient pool requiring highly individualized mobility solutions.

The most attractive growth areas will include digitally captured and designed devices, additive manufacturing, adjustable sockets, advanced liners, microprocessor lower-limb prosthetics, personalized myoelectric upper-limb systems, lightweight neurological orthoses, pediatric mobility systems, and scalable digital fabrication platforms.

The market’s economics will increasingly favor solutions that reduce repeated casting, shorten fabrication time, improve first-fit accuracy, document outcomes, accommodate anatomical changes, simplify replacement, and improve patient adherence. For hospitals and payers, the value proposition will be framed around mobility, safety, rehabilitation efficiency, falls, functional independence, and downstream utilization rather than the purchase price of a device alone.

Regionally, the South will remain the largest market because of population scale, diabetes burden, older-adult growth, and expanding healthcare infrastructure. The West is expected to produce the fastest growth because of demographic expansion, digital adoption, additive manufacturing, and strong medtech innovation. The Northeast will remain disproportionately important for high-complexity cases and clinical research, while the Midwest will provide a durable base of chronic-disease and rehabilitation demand.

For manufacturers, providers, investors, and healthcare systems assessing this market, the central strategic issue is no longer whether customization will remain important. Prosthetics and orthotics are intrinsically moving toward deeper personalization. The more consequential question is which organizations can industrialize personalization without weakening clinical quality.

Companies that combine patient-specific design, skilled clinical fitting, digital manufacturing, evidence generation, payer navigation, scalable fabrication, and long-term follow-up will be best positioned to capture the U.S. market through 2032.